• OPEN AN ACCOUNT
Indian Indices
Sensex
71,593.24 -1,045.46
( -1.44%)
Global Indices
Nasdaq
51,194.40 -347.88
(-0.67%)
Dow Jones
7,822.15 -17.78
(-0.23%)
Hang Seng
69,343.08 -692.63
(-0.99%)
Nikkei 225
10,441.54 -16.96
(-0.16%)
Forex
USD-INR
96.37 0.10
(0.10%)
EUR-INR
108.33 0.45
(0.42%)
GBP-INR
127.68 0.44
(0.34%)
JPY-INR
0.61 0.00
(0.01%)

EQUITY - MARKET SCREENER

Paragon Fine and Speciality Chemical Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
91901
INE0N4G01012
50.3133497
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PARAGON
11.48
103.8
EPS(TTM)
Face Value()
Div & Yield %
4.62
10
0
 

vikas globalone ltd
InvaGen receives EIR report for its facility in Hauppauge, New York
Aug 04,2026
Cipla announced that its wholly owned subsidiary, InvaGen Pharmaceuticals (InvaGen) has received the Establishment Inspection Report (EIR) from the USFDA, indicating the closure of the inspection of its manufacturing facility located at Hauppauge, Long Island, New York, USA.